|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：D535823 |
| 產(chǎn)品名稱：DOTA Zoledronate |
| 產(chǎn)品CAS：1908409-18-6 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
D535823 |
| 名稱: |
DOTA Zoledronate |
| 別名: |
2,2',2''-(10-(2-((2-(1-(2-Hydroxy-2,2-diphosphonoethyl)-1H-imidazol-4-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid |
| CAS號(hào): |
1908409-18-6 |
| 分子式: |
C??H??N?O??P? |
| 分子量: |
701.56 |
| 種類: |
Building Blocks; |
| 應(yīng)用: |
DOTA Zoledronate is a reactant used in the therapy of bone diseases interacting with metal isotopes and undergoing chelation. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
